Akero Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €411.41M +248.6% €92.73M -144.7% 22.5% +2.0 pp N/A N/A
    (estimated) €118.01M +∞% -€207.44M -39.8% -175.8% -1.8 pp N/A N/A
    (estimated) €0.00 +NaN% -€344.43M +14.8% N/A -€255.33M -1.5% N/A
    (estimated) €0.00 +NaN% -€299.96M +16.4% N/A -€259.11M +14.4% N/A
    (estimated) €0.00 +NaN% -€257.61M +18.5% N/A -€226.53M +14.1% N/A
    €0.00 +NaN% -€217.42M +66.1% N/A -€198.49M +58.3% N/A
    €0.00 +NaN% -€130.91M +39.3% N/A -€125.39M +57.1% N/A
    €0.00 +NaN% -€93.94M +8.1% N/A -€79.80M +16.1% N/A
    €0.00 +NaN% -€86.89M +27.2% N/A -€68.73M +12.8% N/A
    €0.00 +NaN% -€68.31M +81.0% N/A -€60.95M +98.3% N/A
    €0.00 +NaN% -€37.74M -46.5% N/A -€30.73M -9,600.5% N/A
    €0.00 +NaN% -€70.49M +1,690.4% N/A €323.47K -108.6% N/A
    €0.00 -€3.94M N/A -€3.78M N/A

    Notifications